The Medical Affairs Essentials Summer School is a unique chance for professionals in this increasingly important function to both deepen and broaden their skills and abilities in the areas of KOL communication, stakeholder engagement, late-phase study development and implementation, as well as to demonstrate the value of a product in clinical, but also economic terms.
Medical affairs and MSL executives are increasingly being expected to improve their capabilities, in line with the medical affairs department’s increasingly central role in the Pharmaceutical or MedTech organization. Medical affairs and liaisons need to deepen their ability to communicate and engage with KOLs, external experts and other stakeholders and this increasingly requires more powerful “soft skills” such as communication and persuasion. Furthermore, in terms of written communication, medical writing skills are as important as ever and working closely with KOLs and investigators to produce interesting publications that appeal to a broad audience is key. Medical affairs professionals also need to improve their technical expertise in areas like late-phase trial design and the implementation of real-world, observational studies, to maximize the opportunity to capture essential evidence of product value. Furthermore, when developing late-phase evidence, medical affairs now need to work more closely with market access and health economic teams to understand what data they require in order to satisfy payers who make decisions based on the economic value of a therapy. The cost and budgetary-effectiveness of a drug or device also increasingly needs to be communicated to external experts and prescribers. This compact, 2-day training and refresher course will enable all participants with the fundamentals to carry out their Medical Affairs activities at the standard of today’s “best practices”.
Who will benefit:
- Medical Affairs Managers
- Medical Directors
- Medical Science Liaison and field medical
- Medical Advisors
- Health Outcomes Liaison
- KOL and External Stakeholder Engagement
- Medical Communications
- Publication & CME Executives
